Hypertriglyceridemia-Related Pancreatitis In Patients With Type 2 Diabetes: Links And Risks

References

• Aguilar M , Bhuket T , Torres S , Liu B , Wong RJ . Prevalence of the metabolic syndrome in the United States, 2003-2012. Jama . 2015;313(19):1973–1974. doi:10.1001/jama.2015.4260 25988468
   PubMed Web of Science ®Google Scholar
• Xiao AY , Tan ML , Wu LM , et al. Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies. Lancet Gastroenterol Hepatol . 2016;1:45–55. doi:10.1016/S2468-1253(16)30004-8 28404111
   PubMed Web of Science ®Google Scholar
• Yadav D , Lowenfels AB . Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas . 2006;33:323–330. doi:10.1097/01.mpa.0000236733.31617.52 17079934
   PubMed Web of Science ®Google Scholar
• Peery AF , Crockett SD , Barritt AS , et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology . 2015;149:1731–1741. doi:10.1053/j.gastro.2015.08.045 26327134
   PubMed Web of Science ®Google Scholar
• Das S , Mahakkanukrauh P , Ho CC . The burden of gastrointestinal, liver, and pancreatic diseases: the global scenario. Gastroenterology . 2016;150:1045–1046.
   Web of Science ®Google Scholar
• Johnson CD , Abu-Hilal M . Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. Gut . 2004;53:1340–1344. doi:10.1136/gut.2004.039883 15306596
   PubMed Web of Science ®Google Scholar
• Mole DJ , Olabi B , Robinson V , et al. Incidence of individual organ dysfunction in fatal acute pancreatitis: analysis of 1024 death records. HPB (Oxford) . 2009;11:166–170. doi:10.1111/j.1477-2574.2009.00038.x 19590643
   PubMed Web of Science ®Google Scholar
• Forsmark CE , Vege SS , Wilcox CM . Acute pancreatitis. N Engl J Med . 2016;375:1972–1981. doi:10.1056/NEJMra1505202 27959604
   PubMed Web of Science ®Google Scholar
• Banks PA , Bollen TL , Dervenis C , et al. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut . 2013;62:102–111. doi:10.1136/gutjnl-2012-302779 23100216
   PubMed Web of Science ®Google Scholar
• Wu BU , Pandol SJ , Liu IL . Simvastatin is associated with reduced risk of acute pancreatitis: findings from a regional integrated healthcare system. Gut . 2015;64:133–138. doi:10.1136/gutjnl-2013-306564 24742713
   PubMed Web of Science ®Google Scholar
• Miller M , Stone NJ , Ballantyne C , et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation . 2011;123:2292–2333.21502576
   PubMed Web of Science ®Google Scholar
• Beltran-Sanchez H , Harhay MO , Harhay MM , McElligott S . Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010. J Am Coll Cardiol . 2013;62(8):697–703. doi:10.1016/j.jacc.2013.05.064 23810877
   PubMed Web of Science ®Google Scholar
• Christian JB , Bourgeois N , Snipes R , Lowe KA . Prevalence of severe (500 to 2000 mg/dl) hypertriglyceridemia in United States adults. Am J Cardiol . 2011;107(6):891–897. doi:10.1016/j.amjcard.2010.11.028 21247544
   PubMed Web of Science ®Google Scholar
• Ford ES , Li C , Zhao G , Pearson WS , Mokdad AH . Hypertriglyceridemia and its pharmacologic treatment among US adults. Arch Intern Med . 2009;169:572–578.19307519
   PubMedGoogle Scholar
• Tada H , Kawashiri MA , Nakahashi T , et al. Clinical characteristics of Japanese patients with severe hypertriglyceridemia. J Clin Lipidol . 2015;9(4):519–524.26228669
   PubMed Web of Science ®Google Scholar
• Retterstøl K , Narverud I , Selmer R , et al. Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics. Lipids Health Dis . 2017;16(1):115. doi:10.1186/s12944-017-0565-8 28606150
   PubMed Web of Science ®Google Scholar
• Zafrir B , Jubran A , Hijazi R , et al. Clinical features and outcomes of severe, very severe, and extreme hypertriglyceridemia in a regional health service. J Clin Lipidol . 2018;12:928–936. doi:10.1016/j.jacl.2018.04.013 29685592
   PubMed Web of Science ®Google Scholar
• Berglund L , Brunzell JD , Goldberg AC , et al. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab . 2012;97(9):2969–2989. doi:10.1210/jcem.97.9.zeg31a 22962670
   PubMed Web of Science ®Google Scholar
• Fredrickson DS , Levy RI , Lees RS . Fat transport in lipoproteins–an integrated approach to mechanisms and disorders. N Engl J Med . 1967;276(5):273–281. doi:10.1056/NEJM196702022760507 5334042
   PubMed Web of Science ®Google Scholar
• Hegele RA , Ginsberg HN , Chapman MJ , et al. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. Lancet Diabetes Endocrinol . 2014;2:655–666.24731657
   PubMed Web of Science ®Google Scholar
• Lewis GF , Xiao C , Hegele RA . Hypertriglyceridemia in the genomic era: a new paradigm. Endocr Rev . 2015;36(1):131–147. doi:10.1210/er.2014-1062 25554923
   PubMed Web of Science ®Google Scholar
• Nordestgaard BG , Benn M , Schnohr P , Tybjaerg-Hansen A . Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. Jama . 2007;298(3):299–308. doi:10.1001/jama.298.3.299 17635890
   PubMed Web of Science ®Google Scholar
• Varbo A , Benn M , Tybjærg-Hansen A , Jørgensen AB , Frikke-Schmidt R , Nordestgaard BG . Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol . 2013;61(4):427–436.23265341
   PubMed Web of Science ®Google Scholar
• Nordestgaard BG . Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology. Circ Res . 2016;118(4):547–563.26892957
   PubMed Web of Science ®Google Scholar
• Nordestgaard BG , Zilversmit DB . Large lipoproteins are excluded from the arterial wall in diabetic cholesterol-fed rabbits. J Lipid Res . 1988;29:1491–1500.3241125
   PubMed Web of Science ®Google Scholar
• Brunzell JD , Deeb SS . Familial lipoprotein lipase deficiency, apo CII defiency, and hepatic lipase deficiency In: Scriver CR , Beaudet AL , Sly WS , Valle D , editors. The Metabolic & Molecular Bases of Inherited Disease . 8 ed. New York: McGraw-Hill; 2001:2789–2816.
   Google Scholar
• Gan SI , Edwards AL , Symonds CJ , et al. Hypertriglyceridemia-induced pancreatitis: a case-based review. World J Gastroenterol . 2006;12:7197–7202. doi:10.3748/wjg.v12.i44.7197 17131487
   PubMed Web of Science ®Google Scholar
• Carr RA , Rejowski BJ , Cote GA , Pitt HA , Zyromski NJ . Systematic review of hypertriglyceridemia-induced acute pancreatitis: a more virulent etiology? Pancreatology . 2016;16:469–476.27012480
   PubMed Web of Science ®Google Scholar
• Brown WV , Goldberg I , Duell B , Gaudet D . Roundtable discussion: familial chylomicronemia syndrome: diagnosis and management. J Clin Lipidol . 2018;12:254–263. doi:10.1016/j.jacl.2018.04.013 29534878
   PubMed Web of Science ®Google Scholar
• Amblee A , Mohananey D , Morkos M , et al. Acute pancreatitis in patients with severe hypertriglyceridemia in a multiethnic minority population. Endocr Pract . 2018;24:429–436.29498913
   PubMed Web of Science ®Google Scholar
• Adiamah A , Psaltis E , Crook M , Lobo DN . A systematic review of the epidemiology, pathophysiology and current management of hyperlipidaemic pancreatitis. Clin Nutr . 2018;37:1810–1822. doi:10.1016/j.clnu.2017.09.028 29056284
   PubMed Web of Science ®Google Scholar
• Rashid N , Sharma PP , Scott RD , et al. Severe hypertriglyceridemia and factors associated with acute pancreatitis in an integrated health care system. J Clin Lipidol . 2016;10:880–890. doi:10.1016/j.jacl.2016.05.006 27578119
   PubMed Web of Science ®Google Scholar
• Pedersen SB , Langsted A , Nordestgaard BG . Nonfasting mild to moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Intern Med . 2016;176(12):1834–1842. doi:10.1001/jamainternmed.2016.6875 27820614
   PubMed Web of Science ®Google Scholar
• Scherer J , Singh VP , Pitchumoni CS , et al. Issues in hypertriglyceridemic pancreatitis: an update. J Clin Gastroenterol . 2014;48:195–203.24172179
   PubMed Web of Science ®Google Scholar
• Wang GJ , Gao CF , Wei D , Wang C , Ding SQ . Acute pancreatitis: etiology and common pathogenesis. World J Gastroenterol . 2009;15(12):1427–1430. doi:10.3748/wjg.15.1427 19322914
   PubMed Web of Science ®Google Scholar
• Christophersen B , Nordstoga K , Shen Y , et al. Lipoprotein lipase deficiency with pancreatitis in mink: biochemical characterization and pathology. J Lipid Res . 1997;38:837–846.9186902
   PubMed Web of Science ®Google Scholar
• Nordstoga K , Christophersen B , Ytrehus B , et al. Pancreatitis associated with hyperlipoproteinaemia type I in mink (Mustela vison): earliest detectable changes occur in mitochondria of exocrine cells. J Comp Pathol . 2006;134:320–328. doi:10.1016/j.jcpa.2005.11.001 16709420
   PubMed Web of Science ®Google Scholar
• Navina S , Acharya C , DeLany JP , et al. Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity. Sci Transl Med . 2011;3:107ra10.
   Web of Science ®Google Scholar
• Hansen SEJ , Madsen CM , Varbo A , Nordestgaard BRG . Low grade inflammation in the association between mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis: a study of more than 115,000 individuals from the general population. Clin Chem . 2018;65:321–332. doi:10.1373/clinchem.2018.294926 30518661
   PubMed Web of Science ®Google Scholar
• Xie SL , Chen TZ , Huang XL , et al. Genetic variants associated with gestational hypertriglyceridemia and pancreatitis. PLoS One . 2015;10(6):e0129488. doi:10.1371/journal.pone.0129488 26079787
   PubMed Web of Science ®Google Scholar
• Vivatrat N , Barshop BA , Jones KL . Severe hypertriglyceridemia and recurrent pancreatitis in a girl with type Ia glycogen storage disease and type III hyperlipoproteinemia. Am J Med Genet A . 2009;149A:2557–2559.19842193
   PubMed Web of Science ®Google Scholar
• Garg A . Clinical review: lipodystrophies: genetic and acquired body fat disorders. J Clin Endocrinol Metab . 2011;96:3313–3325. doi:10.1210/jc.2011-1159 21865368
   PubMed Web of Science ®Google Scholar
• Krishna SG , Kamboj AK , Hart PA , et al. The changing epidemiology of acute pancreatitis hospitalizations: a decade of trends and the impact of chronic pancreatitis. Pancreas . 2017;46:482–488. doi:10.1097/MPA.0000000000000783 28196021
   PubMed Web of Science ®Google Scholar
• Mikolasevic I , Milic S , Orlic L , et al. Metabolic syndrome and acute pancreatitis. Eur J Intern Med . 2016;32:79–83. doi:10.1016/j.ejim.2016.04.004 27157403
   PubMed Web of Science ®Google Scholar
• Leone P , Barkin JA , Barkin JS . Are triglycerides the cause or simply the effect of worsening acute pancreatitis severity? J Clin Gastroenterol . 2019;53(6):470–471. doi:10.1097/MCG.0000000000000953
   Web of Science ®Google Scholar
• Wan J , He W , Zhu Y , et al. Stratified analysis and clinical significance of elevated serum triglyceride levels in early acute pancreatitis: a retrospective study. Lipids Health Dis . 2017;16:124. doi:10.1186/s12944-017-0565-8 28655321
   PubMed Web of Science ®Google Scholar
• Wang Q , Wang G , Qiu Z , et al. Elevated serum triglycerides in the prognostic assessment of acute pancreatitis: a systematic review and meta-analysis of observational studies. J Clin Gastroenterol . 2017;51:586–593.28682990
   PubMed Web of Science ®Google Scholar
• Nawaz H , Koutroumpakis E , Easler J , et al. Elevated serum triglycerides are independently associated with persistent organ failure in acute pancreatitis. Am J Gastroenterol . 2015;110:1497–1503.26323188
   PubMed Web of Science ®Google Scholar
• Sue LY , Batech M , Yadav D , et al. Effect of serum triglycerides on clinical outcomes in acute pancreatitis: findings from a regional integrated health care system. Pancreas . 2017;46(7):874–879. doi:10.1097/MPA.0000000000000860 28697126
   PubMed Web of Science ®Google Scholar
• Zhang R , Deng L , Jin T , et al. Hypertriglyceridaemia-associated acute pancreatitis: diagnosis and impact on severity. HPB (Oxford) . 2019;21:1240–1249. Epub ahead of print. doi:10.1016/j.hpb.2019.01.015.30885545
   PubMed Web of Science ®Google Scholar
• Rashid N , Sharma PP , Scott RD , et al. All-cause and acute pancreatitis health care costs in patients with severe hypertriglyceridemia. Pancreas . 2017;46:57–63. doi:10.1097/MPA.0000000000000704 27518471
   PubMed Web of Science ®Google Scholar
• Guda NM , Muddana V , Whitcomb DC , et al. Recurrent acute pancreatitis: international state-of-the-science conference with recommendations. Pancreas . 2018;47:653–666. doi:10.1097/MPA.0000000000001178 29894415
   PubMed Web of Science ®Google Scholar
• Lankisch PG , Breuer N , Bruns A , et al. Natural history of acute pancreatitis: a long-term population-based study. Am J Gastroenterol . 2009;104:2797–2805. doi:10.1038/ajg.2009.405 19603011
   PubMed Web of Science ®Google Scholar
• Yadav D , O’Connell M , Papachristou GI . Natural history following the first attack of acute pancreatitis. Am J Gastroenterol . 2012;107:1096–1103. doi:10.1038/ajg.2012.126 22613906
   PubMed Web of Science ®Google Scholar
• Takeyama Y . Long-term prognosis of acute pancreatitis in Japan. Clin Gastroenterol Hepatol . 2009;7(11 Suppl):S15–S17.19896091
   PubMed Web of Science ®Google Scholar
• Bertilsson S , Swärd P , Kalaitzakis E . Factors that affect disease progression after first attack of acute pancreatitis. Clin Gastroenterol Hepatol . 2015;13:1662–1669. doi:10.1016/j.cgh.2015.04.012 25911118
   PubMed Web of Science ®Google Scholar
• Vipperla K , Somerville C , Furlan A , et al. Clinical profile and natural course in a large cohort of patients with hypertriglyceridemia and pancreatitis. J Clin Gastroenetrol . 2017;51:77–85. doi:10.1097/MCG.0000000000000579
   Web of Science ®Google Scholar
• Zafrir B , Saliba W , Jubran A , Hijazi R , Shapira C . Severe hypertriglyceridemia-related pancreatitis: characteristics and predictors of recurrence. Pancreas . 2019;48(2):182–186. doi:10.1097/MPA.0000000000001235 30629026
   PubMed Web of Science ®Google Scholar
• Charlesworth A , Steger A , Crook MA . Acute pancreatitis associated with severe hypertriglyceridemia: a retrospective cohort study. Int J Surg . 2015;23:23–27.26391596
   PubMed Web of Science ®Google Scholar
• Wu BU , Batech M , Dong EY , Duan L , Yadav D , Chen W . Influence of ambulatory triglyceride levels on risk of recurrence in patients with hypertriglyceridemic pancreatitis. Dig Dis Sci . 2019;64(3):890–897. doi:10.1007/s10620-018-5226-x 30094622
   PubMed Web of Science ®Google Scholar
• Hirano T . Pathophysiology of Diabetic Dyslipidemia. J Atheroscler Thromb . 2018;25(9):771–782. doi:10.5551/jat.RV17023 29998913
   PubMed Web of Science ®Google Scholar
• Vergès B . Pathophysiology of diabetic dyslipidaemia: where are we? Diabetologia . 2015;58(5):886–899. doi:10.1007/s00125-015-3525-8 25725623
   PubMed Web of Science ®Google Scholar
• Soran H , Schofield JD , Adam S , Durrington PN . Diabetic dyslipidaemia. Curr Opin Lipidol . 2016;27(4):313–322. doi:10.1097/MOL.0000000000000318 27213628
   PubMed Web of Science ®Google Scholar
• Mora S , Buring JE , Ridker PM . Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events. Circulation . 2014;129(5):553–561. doi:10.1161/CIRCULATIONAHA.113.005873 24345402
   PubMed Web of Science ®Google Scholar
• Tehrani DM , Zhao Y , Blaha MJ , et al. Discordance of low-density lipoprotein and high-density lipoprotein cholesterol particle versus cholesterol concentration for the prediction of cardiovascular disease in patients with metabolic syndrome and diabetes mellitus. Am J Cardiol . 2016;117(12):1921–1927. doi:10.1016/j.amjcard.2016.03.040 27156827
   PubMed Web of Science ®Google Scholar
• Jaiswal M , Schinske A , Pop-Busui R . Lipids and lipid management in diabetes. Best Pract Res Clin Endocrinol Metab . 2014;28(3):325–338. doi:10.1016/j.beem.2013.12.001 24840262
   PubMed Web of Science ®Google Scholar
• Taskinen MR , Borén J . New insights into the pathophysiology of dyslipidemia in type 2 diabetes. Atherosclerosis . 2015;239(2):483–495. doi:10.1016/j.atherosclerosis.2015.01.039 25706066
   PubMed Web of Science ®Google Scholar
• Girman CJ , Kou TD , Cai B , et al. Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes. Diabetes Obes Metab . 2010;12:766–771. doi:10.1111/j.1463-1326.2010.01231.x 20649628
   PubMed Web of Science ®Google Scholar
• Noel RA , Braun DK , Patterson RE , et al. Increased risk of acute pancreatitis and biliary disease observed in patients with type 2 diabetes: a retrospective cohort study. Diabetes Care . 2009;32:834–838. doi:10.2337/dc08-1755 19208917
   PubMed Web of Science ®Google Scholar
• Lai SW , Muo CH , Liao KF , et al. Risk of acute pancreatitis in type 2 diabetes and risk reduction on anti-diabetic drugs: a population-based cohort study in Taiwan. Am J Gastroenterol . 2011;106:1697–1704.21577242
   PubMed Web of Science ®Google Scholar
• Gonzalez-Perez A , Schlienger RG , Rodríguez LA . Acute pancreatitis in association with type 2 diabetes and anti-diabetic drugs: a population based cohort study. Diabetes Care . 2010;33:2580–2585. doi:10.2337/dc10-0842 20833867
   PubMed Web of Science ®Google Scholar
• Blomgren KB , Sundstrom A , Steineck G , et al. Obesity and treatment of diabetes with glyburide may both be risk factors for acute pancreatitis. Diabetes Care . 2002;25:298–302. doi:10.2337/diacare.25.2.298 11815499
   PubMed Web of Science ®Google Scholar
• Christian JB , Arondekar B , Buysman EK , Jacobson TA , Snipes RG , Horwitz RI . Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia. Am J Med . 2014;127(1):36–44. doi:10.1016/j.amjmed.2014.10.004 24384100
   PubMed Web of Science ®Google Scholar
• Rickels MR , Bellin M , Toledo FG , et al. Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012. Pancreatology . 2013;13(4):336–342. doi:10.1016/j.pan.2013.05.002 23890130
   PubMed Web of Science ®Google Scholar
• Kleeff J , Whitcomb DC , Shimosegawa T , et al. Chronic pancreatitis. Nat Rev Dis Primers . 2017;3:17060.28880010
   PubMed Web of Science ®Google Scholar
• Bellin MD , Whitcomb DC , Abberbock J , et al. Patient and disease characteristics associated with the presence of diabetes mellitus in adults with chronic pancreatitis in the United States. Am J Gastroenterol . 2017;112(9):1457–1465. doi:10.1038/ajg.2017.181 28741615
   PubMed Web of Science ®Google Scholar
• Cui Y , Andersen DK . Pancreatogenic diabetes: special considerations for management. Pancreatology . 2011;11:279–294. doi:10.1159/000329188 21757968
   PubMed Web of Science ®Google Scholar
• Gardner TB , Vege SS , Chari ST , et al. Faster rate of initial fluid resuscitation in severe acute pancreatitis diminishes inhospital mortality. Pancreatology . 2009;9:770–776. doi:10.1159/000210022 20110744
   PubMed Web of Science ®Google Scholar
• Gardner TB , Vege SS , Pearson RK , Chari ST . Fluid resuscitation in acute pancreatitis. Clin Gastroenterol Hepatol . 2008;6:1070–1076. doi:10.1016/j.cgh.2008.05.005 18619920
   PubMed Web of Science ®Google Scholar
• Vege DMJ , Forsmark CE , Martel M , Barkun AN . Initial medical treatment of acute pancreatitis: American Gastroenterological Association Institute technical review. Gastroenterology . 2018;154(4):1103–1139. doi:10.1053/j.gastro.2018.01.031 29421596
   PubMed Web of Science ®Google Scholar
• Isenmann R , Rünzi M , Kron M , et al. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology . 2004;126:997–1004. doi:10.1053/j.gastro.2003.12.050 15057739
   PubMed Web of Science ®Google Scholar
• Dellinger EP , Tellado JM , Soto NE , et al. Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled study. Ann Surg . 2007;245:674–683. doi:10.1097/01.sla.0000250414.09255.84 17457158
   PubMed Web of Science ®Google Scholar
• Villatoro E , Mulla M , Larvin M . Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev . 2010;5:CD002941.
   Google Scholar
• Lim CL , Lee W , Liew YX , Tang SS , Chlebicki MP , Kwa AL . Role of antibiotic prophylaxis in necrotizing pancreatitis: a meta-analysis. J Gastrointest Surg . 2015;19:480–491. doi:10.1007/s11605-014-2662-6 25608671
   PubMed Web of Science ®Google Scholar
• Petrov MS , McIlroy K , Grayson L , et al. Early nasogastric tube feeding versus nil per os in mild to moderate acute pancreatitis: a randomized controlled trial. Clin Nutr . 2013;32:697–703. doi:10.1016/j.clnu.2012.12.011 23340042
   PubMed Web of Science ®Google Scholar
• Sathiaraj E , Murthy S , Mansard MJ , et al. Clinical trial: oral feeding with a soft diet compared with clear liquid diet as initial meal in mild acute pancreatitis. Aliment Pharmacol Ther . 2008;28:777–781. doi:10.1111/j.1365-2036.2008.03794.x 19145732
   PubMed Web of Science ®Google Scholar
• Eckerwall GE , Tingstedt BB , Bergenzaun PE , et al. Immediate oral feeding in patients with mild acute pancreatitis is safe and may accelerate recovery — a randomized clinical study. Clin Nutr . 2007;26:758–763. doi:10.1016/j.clnu.2007.04.007 17719703
   PubMed Web of Science ®Google Scholar
• Greenberg J , Hsu J , Bawazeer M , et al. Clinical practice guideline: management of acute pancreatitis. Can J Surg . 2016;59(2):128–140.27007094
   PubMed Web of Science ®Google Scholar
• Oikawa S , Yamashita S , Nakaya N , et al. Efficacy and safety of long-term coadministration of fenofibrate and ezetimibe in patients with combined hyperlipidemia: results of the EFECTL study. J Atheroscler Thromb . 2017;24(1):77–94. doi:10.5551/jat.35626 27397061
   PubMed Web of Science ®Google Scholar
• Ansquer JC , Bekaert I , Guy M , et al. Efficacy and safety of coadministration of fenofibrate and ezetimibe compared with each as monotherapy in patients with type IIb dyslipidemia and features of the metabolic syndrome: a prospective, randomized, double-blind, three-parallel arm, multicenter, comparative study. Am J Cardiovasc Drugs . 2009;9(2):91–101.19331437
   PubMed Web of Science ®Google Scholar
• Barter PJ , Rye KA . Cardioprotective properties of fibrates: which fibrate, which patients, what mechanism? Circulation . 2006;113:1553–1555. doi:10.1161/CIRCULATIONAHA.105.620450 16567579
   PubMed Web of Science ®Google Scholar
• Rubins HB , Robins SJ , Collins D , et al. Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT). Arch Intern Med . 2002;162:2597–2604. doi:10.1001/archinte.162.22.2597 12456232
   PubMed Web of Science ®Google Scholar
• Jun M , Foote C , Lv J , et al. Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet . 2010;375(9729):1875–1884. doi:10.1016/S0140-6736(10)60656-3 20462635
   PubMed Web of Science ®Google Scholar
• Wang D , Liu B , Tao W , Hao Z , Liu M . Fibrates for secondary prevention of cardiovascular disease and stroke. Cochrane Database Syst Rev . 2016;11:CD009753. doi:10.1002/14651858.CD011360.pub2 27849333
   PubMed Web of Science ®Google Scholar
• Pradhan AD , Paynter NP , Everett BM , et al. Rationale and design of the pemafibrate to reduce cardiovascular outcomes by reducing triglycerides in patients with diabetes (PROMINENT) study. Am Heart J . 2018;206:80–93. doi:10.1016/j.ahj.2018.09.011 30342298
   PubMed Web of Science ®Google Scholar
• Harris WS , Bulchandani D . Why do omega-3 fatty acids lower serum triglycerides? Curr Opin Lipidol . 2006;17(4):387–393. doi:10.1097/01.mol.0000236363.63840.16 16832161
   PubMed Web of Science ®Google Scholar
• Stroes ESG , Susekov AV , de Bruin TWA , Kvarnström M , Yang H , Davidson MH . Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial. J Clin Lipidol . 2018;12(2):321–330. doi:10.1016/j.jacl.2017.10.012 29289538
   PubMed Web of Science ®Google Scholar
• Borow KM , Nelson JR , Mason RP . Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis. Atherosclerosis . 2015;242:357–366. doi:10.1016/j.atherosclerosis.2015.07.035 26253795
   PubMed Web of Science ®Google Scholar
• Yokoyama M , Origasa H , Matsuzaki M . Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet . 2007;369(9567):1090–1098. doi:10.1016/S0140-6736(07)60527-3 17398308
   PubMed Web of Science ®Google Scholar
• Bhatt DL , Steg PG , Miller M , et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med . 2019;380(1):11–22. doi:10.1056/NEJMoa1812792 30415628
   PubMed Web of Science ®Google Scholar
• Doggrell SA . Clinical trials of eicosapentaenoic acid (EPA) prescription products for the treatment of hypertriglyceridemia. Expert Opin Pharmacother . 2019;20(10):1221–1225. doi:10.1080/14656566.2019.1609942 31038369
   PubMed Web of Science ®Google Scholar
• Kamanna VS , Kashyap ML . Mechanism of action of niacin on lipoprotein metabolism. Curr Atheroscler Rep . 2000;2:36–46.11122723
   PubMedGoogle Scholar
• Kamanna VS , Kashyap ML . Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents? Am J Cardiol . 2007;100:S53–S61. doi:10.1016/j.amjcard.2007.09.080 18047854
   PubMed Web of Science ®Google Scholar
• Boden WE , Probstfield JL , Anderson T , et al.; AIM-HIGH Investigators. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med . 2011;365(24):2255–2267. doi:10.1056/NEJMoa1107579.22085343
   PubMed Web of Science ®Google Scholar
• Landray MJ , Haynes R , Hopewell JC , et al.; HPS2-THRIVE Collaborative Group. Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med . 2014;371(3):203–212. doi:10.1056/NEJMoa1300955.25014686
   PubMed Web of Science ®Google Scholar
• Ong JM , Kirchgessner TG , Schotz MC , Kern PA . Insulin increases the synthetic rate and messenger RNA level of lipoprotein lipase in isolated rat adipocytes. J Biol Chem . 1988;253(12):933–938.
   Google Scholar
• Mikhail N , Trivedi K , Page C , Wali S , Cope D . Treatment of severe hypertriglyceridemia in nondiabetic patients with insulin. Am J Emerg Med . 2005;23:415–417. doi:10.1016/j.ajem.2005.02.036 15915436
   PubMed Web of Science ®Google Scholar
• Tamez-Perez HE , Saenz-Gallegos R , Hernandez-Rodriguez K , et al. Insulin therapy in patients with severe hypertriglyceridemia. Rev Med Inst Mex Seguro Soc . 2006;44:235–237.16870117
   PubMedGoogle Scholar
• Chen JH , Yeh JH , Lai HW , et al. Therapeutic plasma exchange in patients with hyperlipidemic pancreatitis. World J Gastroenterol . 2004;10:2272–2274.15259080
   PubMed Web of Science ®Google Scholar
• Dehal H , Adashek M . Total plasma exchange in hypertriglyceridemia-induced pancreatitis: case report and literature review. Case Rep Med . 2018;2018:4017573.29686710
   PubMed Web of Science ®Google Scholar
• Näsström B , Olivecrona G , Olivecrona T , Stegmayr BG . Lipoprotein lipase during continuous heparin infusion: tissue stores become partially depleted. J Lab Clin Med . 2001;138(3):206–213. doi:10.1067/mlc.2001.117666 11528374
   PubMed Web of Science ®Google Scholar
• Brahm AJ , Hegele RA . Lomitapide for the treatment of hypertriglyceridemia. Expert Opin Investig Drugs . 2016;25(12):1457–1463. doi:10.1080/13543784.2016.1254187
   PubMed Web of Science ®Google Scholar
• Carpentier AC , Frisch F , Labbé SM , et al. Effect of alipogene tiparvovec (AAV1-LPL(S447X)) on postprandial chylomicron metabolism in lipoprotein lipase-deficient patients. J Clin Endocrinol Metab . 2012;97:1635–1644. doi:10.1210/jc.2011-3002 22438229
   PubMed Web of Science ®Google Scholar
• Senior M . After Glybera’s withdrawal, what’s next for gene therapy? Nature Biotechnol . 2017;35(6):491–493. doi:10.1038/nbt0617-491 28591128
   PubMed Web of Science ®Google Scholar
• Norata GD , Tsimikas S , Pirillo A , Catapano AL . Apolipoprotein C-III: from pathophysiology to pharmacology. Trends Pharmacol Sci . 2015;36(10):675–687. doi:10.1016/j.tips.2015.07.001 26435212
   PubMed Web of Science ®Google Scholar
• Digenio A , Dunbar RL , Alexander VJ , et al. Antisense-mediated lowering of plasma apolipoprotein C-III by volanesorsen improves dyslipidemia and insulin sensitivity in type 2 diabetes. Diabetes Care . 2016;39(8):1408–1415. doi:10.2337/dc16-0126 27271183
   PubMed Web of Science ®Google Scholar
• Graham MJ , Lee RG , Brandt TA , et al. Cardiovascular and metabolic effects of ANGPTL3 antisense oligonucleotides. N Engl J Med . 2017;377(3):222–232. doi:10.1056/NEJMoa1701329 28538111
   PubMed Web of Science ®Google Scholar